Entries by Editorial Team

Reuters

(11/20/15) Brian Smoluch interviewed by Reuters on November 20, 2015 regarding the rapidly evolving solar markets.

Morningstar Rating™

(11/30/18) Hood River Capital Management is pleased to announce that the Hood River Small Cap Growth Fund (HRSMX) has received a 4-Star Overall Morningstar Rating™ […]

Small-Cap Growth – March 31, 2015

The first quarter of 2015 was another good one for small cap stocks, with the Russell 2000® Growth Index up 6.6%. Hood River’s Small-Cap Growth strategy outperformed the index for the quarter, driven primarily by our bottom-up stock picking. Small cap stocks benefited from sustained favorable economic conditions during the period. Labor markets continued to […]

Small-Cap Growth – December 31, 2014

The fourth quarter of 2014 was an exciting one for Hood River Capital Management as we entered into an agreement to gain 100% ownership of the firm, up from the 65% that our investment team currently owns. This represents the final step in the process of becoming a fully independent, employee-owned firm that is solely […]

Small-Cap Growth – September 30, 2014

Hood River’s Small-Cap Growth strategy had a strong third quarter as we outperformed the Russell 2000® Growth Index by over 380 basis points net of fees, leaving us ahead of the index by more than 500 basis points year-to-date. As usual, our relative performance was driven by bottom-up stock picking, with technology, healthcare and industrials particularly additive […]

Small-Cap Growth – June 30, 2014

For the second quarter of 2014, the Russell 2000® Growth Index posted a modest gain of 1.7%. While this is the eighth consecutive quarter the index has delivered a positive return, it does not begin to tell the story that unfolded throughout the quarter. The correction that began in mid-March continued through mid-May pushing the […]

Small-Cap Growth – March 31, 2014

The Russell 2000® Growth Index was essentially flat for the first quarter, but within the quarter there was considerable volatility driven by sector and factor rotation. The first two months saw dramatic returns in speculative areas like biotech and within aggressive factors like momentum, low quality and high beta stocks. These areas gave back most […]